细胞株Cell Lines 72及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV72
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID NCI-H249
AC CVCL_A537
SY H249; H-249; NCIH249
DR ATCC; CRL-5827
DR BioSample; SAMN03151645
DR BioSample; SAMN03151860
DR BioSample; SAMN03471746
DR Cosmic; 755460
DR Cosmic; 877204
DR Cosmic; 980931
DR Cosmic; 1006529
DR Cosmic; 1021857
DR Cosmic; 1032397
DR Cosmic; 2125249
DR GEO; GSM845545
DR GEO; GSM844646
DR KCLB; 90249
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=20143388;
WW http://www.atcc.org/support/faqs/4bf60/NCIH249%20ATCC%20CRL5827-1073.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5827; true.
CC Discontinued: KCLB; 90249; probable.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 9
ST TH01: 8,9
ST TPOX: 10
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H250
AC CVCL_1554
SY H250; H-250
DR CLO; CLO_0008078
DR ATCC; CRL-5828
DR BioSample; SAMN03471747
DR ChEMBL-Cells; CHEMBL3308294
DR ChEMBL-Targets; CHEMBL2366289
DR Cosmic; 688020
DR Cosmic; 924241
DR Cosmic; 1021858
DR Cosmic-CLP; 924241
DR GDSC; 924241
DR GEO; GSM1670235
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=27397505;
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Brain.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2509
AC CVCL_A538
SY H2509; H-2509
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2527
AC CVCL_A539
SY H2527; H-2527
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2540
AC CVCL_A540
SY H2540; H-2540
RX PubMed=8806092;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2552
AC CVCL_A541
SY H2552; H-2552
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2562
AC CVCL_X977
SY H2562; H-2562
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2580
AC CVCL_A542
SY H2580; H-2580
RX PubMed=8806092;
DI NCIt; C3262; Neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2591
AC CVCL_A543
SY H2591; H-2591
DR BioSample; SAMN03471042
DR Cosmic; 1032379
DR Cosmic-CLP; 1240131
DR GDSC; 1240131
DR GEO; GSM1669821
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,14
ST D13S317: 12
ST D16S539: 10,12
ST D18S51: 12
ST D21S11: 30,32.2
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 8,14
ST FGA: 19,22
ST Penta D: 12
ST Penta E: 5,10
ST TH01: 8
ST TPOX: 8,12
ST vWA: 16,17
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2594
AC CVCL_A544
SY H2594; H-2594
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2595
AC CVCL_A545
SY H2595; H-2595
DR EFO; EFO_0006682
DR BioSample; SAMN03471011
DR Cosmic; 1032381
DR Cosmic; 1087354
DR Cosmic-CLP; 1240132
DR GDSC; 1240132
DR GEO; GSM1669822
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 12,24
ST D21S11: 29,31.2
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 7,9
ST D8S1179: 10,14
ST FGA: 23,25
ST Penta D: 13,14
ST Penta E: 11,13
ST TH01: 6,7
ST TPOX: 11
ST vWA: 15,16
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2596
AC CVCL_A546
SY H2596; H-2596
DR EFO; EFO_0006683
DR BioSample; SAMN03471021
DR Cosmic; 1032390
DR Cosmic; 1087355
DR GDSC; 1240133
RX PubMed=7695406;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 12
ST D18S51: 14
ST D21S11: 29,33.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 13,16
ST FGA: 20
ST Penta D: 12,13
ST Penta E: 12
ST TH01: 6
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2597
AC CVCL_A547
SY H2597; H-2597
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2600
AC CVCL_A548
SY H2600; H-2600
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2618
AC CVCL_A549
SY H2618; H-2618
DR Cosmic; 1032391
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2679
AC CVCL_A550
SY H2679; H-2679
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2691
AC CVCL_A551
SY H2691; H-2691
DR BioSample; SAMN03471020
DR Cosmic; 1087356
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12,13
ST D16S539: 9,12
ST D18S51: 21
ST D21S11: 30,31
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 8,9
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2706
AC CVCL_A552
SY H2706; H-2706
RX PubMed=8806092;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2712
AC CVCL_Y289
SY H2712; H-2712
RX PubMed=11030152;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2722
AC CVCL_U994
SY H2722; H-2722
DR EFO; EFO_0006684
DR BioSample; SAMN03471016
DR Cosmic; 1995413
DR Cosmic-CLP; 1290812
DR GDSC; 1290812
DR GEO; GSM1669823
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y (Cosmic-CLP)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 10,11
ST D13S317: 11 (Cosmic-CLP)
ST D13S317: 7.2,11 (PubMed=25877200)
ST D16S539: 13
ST D18S51: 11,13
ST D21S11: 29,33.2
ST D3S1358: 17
ST D5S818: 9,11
ST D7S820: 10,11
ST D8S1179: 11,15
ST FGA: 23
ST Penta D: 10,13
ST Penta E: 5,19
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2731
AC CVCL_U995
SY H2731; H-2731
DR BioSample; SAMN03471019
DR Cosmic-CLP; 1240134
DR GDSC; 1240134
DR GEO; GSM1669824
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,13 (Cosmic-CLP)
ST D13S317: 11 (PubMed=25877200)
ST D16S539: 13
ST D18S51: 15
ST D21S11: 30,31.2
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 8,14
ST D8S1179: 8,12
ST FGA: 21
ST Penta D: 11,12
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2795
AC CVCL_U996
SY H2795; H-2795
DR EFO; EFO_0006685
DR BioSample; SAMN03471022
DR Cosmic; 1995414
DR Cosmic-CLP; 1290813
DR GDSC; 1290813
DR GEO; GSM1669825
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 11,16
ST D19S433: 15
ST D21S11: 29,30
ST D2S1338: 18,25
ST D3S1358: 14,15
ST D5S818: 9,11
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 23
ST Penta D: 9,13
ST Penta E: 7,13
ST TH01: 6
ST TPOX: 9,11
ST vWA: 17,19
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H28
AC CVCL_1555
SY H28; H-28; HUT-28; HUT 28; HuT 28; HUT28; Hut28; HuT28
DR CLO; CLO_0008079
DR EFO; EFO_0006686
DR ATCC; CRL-5820
DR BioSample; SAMN03471010
DR CCLE; NCIH28_PLEURA
DR ChEMBL-Cells; CHEMBL3308775
DR ChEMBL-Targets; CHEMBL1075541
DR Cosmic; 688059
DR Cosmic; 733814
DR Cosmic; 877108
DR Cosmic; 877350
DR Cosmic; 886387
DR Cosmic; 908470
DR Cosmic; 980995
DR Cosmic; 1032386
DR Cosmic; 1146909
DR Cosmic; 1152495
DR Cosmic; 1481543
DR Cosmic; 1522766
DR Cosmic; 1541208
DR Cosmic; 1749556
DR Cosmic; 1963325
DR Cosmic; 1995572
DR Cosmic; 2474149
DR Cosmic-CLP; 908470
DR GDSC; 908470
DR GEO; GSM434272
DR GEO; GSM726267
DR GEO; GSM794268
DR GEO; GSM887425
DR GEO; GSM888504
DR GEO; GSM1670236
DR IGRhCellID; H28GEO
DR KCLB; 90028
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=21642991;
RX PubMed=22460905;
RX PubMed=23830731;
RX PubMed=24926545;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90028; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 12,13
ST D18S51: 19
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 10,12
ST FGA: 19.2,21
ST Penta D: 9,10
ST Penta E: 10,16
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,15
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2803
AC CVCL_U997
SY H2803; H-2803
DR EFO; EFO_0006687
DR BioSample; SAMN03471013
DR Cosmic; 1995415
DR Cosmic-CLP; 1240135
DR GDSC; 1240135
DR GEO; GSM1669826
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12,13
ST D16S539: 9,12
ST D18S51: 21
ST D21S11: 30,31
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 13
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 8,9
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2804
AC CVCL_U998
SY H2804; H-2804
DR EFO; EFO_0006688
DR BioSample; SAMN03471014
DR Cosmic; 1995416
DR Cosmic-CLP; 1240136
DR GDSC; 1240136
DR GEO; GSM1669827
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9,11
ST D18S51: 18
ST D21S11: 28,30
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 13,15
ST FGA: 23
ST Penta D: 13
ST Penta E: 7,10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2810
AC CVCL_U999
SY H2810; H-2810
DR EFO; EFO_0006689
DR BioSample; SAMN03471017
DR Cosmic-CLP; 1240137
DR GDSC; 1240137
DR GEO; GSM1669828
RX PubMed=23830731;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 10,11
ST D18S51: 12
ST D21S11: 29
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 7,12
ST D8S1179: 13
ST FGA: 20,21.2
ST Penta D: 14
ST Penta E: 8,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2818
AC CVCL_V000
SY H2818; H-2818
DR Cosmic; 1995417
DR Cosmic-CLP; 1290814
DR GDSC; 1290814
DR GEO; GSM1669829
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H285
AC CVCL_A553
SY H285; H-285
DR ATCC; CRL-5829
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Discontinued: ATCC; CRL-5829; true.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2850
AC CVCL_Y290
SY H2850; H-2850
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H2869
AC CVCL_V001
SY H2869; H-2869
DR Cosmic; 1995418
DR Cosmic-CLP; 1240138
DR GDSC; 1240138
DR GEO; GSM1669830
RX PubMed=23830731;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 13
ST D5S818: 12,13
ST D7S820: 7,8
ST TH01: 8
ST TPOX: 8
ST vWA: 16
DI NCIt; C4282; Biphasic mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H2882
AC CVCL_5158
SY H2882; H-2882
DR Cosmic; 755471
DR Cosmic; 903621
DR Cosmic; 1146910
DR GEO; GSM253402
DR GEO; GSM434255
DR GEO; GSM794368
DR IGRhCellID; H2882GEO
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=12759538;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 11
ST D7S820: 9
ST TH01: 9.3
ST TPOX: 11
ST vWA: 16
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S844 ! NCI-BL2882
SX Female
CA Cancer cell line
//
ID NCI-H2887
AC CVCL_5159
SY H2887; H-2887
DR Cosmic; 903622
DR Cosmic; 1146911
DR GEO; GSM253355
DR GEO; GSM434256
DR GEO; GSM794369
DR IGRhCellID; H2887GEO
RX PubMed=10987304;
RX PubMed=11314036;
RX PubMed=12759538;
RX PubMed=20679594;
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 12
ST vWA: 17
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S845 ! NCI-BL2887
SX Male
CA Cancer cell line
//
ID NCI-H289
AC CVCL_A554
SY H289: H-289
DR Cosmic; 877205
DR Cosmic; 1021859
DR Cosmic; 1320183
DR GEO; GSM794279
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10987304;
RX PubMed=11030152;
RX PubMed=11314036;
RX PubMed=20679594;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): PubMed=20679594
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 9
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 17,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E095 ! NCI-BL289
SX Female
CA Cancer cell line
//
ID NCI-H290
AC CVCL_A555
SY H290: H-290; HUT-290; Hut-290; HUT 290; HUT290
DR BioSample; SAMN03471037
DR Cosmic; 733817
DR Cosmic; 877270
DR Cosmic; 877403
DR Cosmic; 886389
DR Cosmic; 980996
DR Cosmic; 1032387
DR Cosmic; 1152498
DR Cosmic; 1995419
DR Cosmic-CLP; 1240139
DR GDSC; 1240139
DR GEO; GSM794280
DR GEO; GSM1669831
DR KCLB; 90290
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=20679594;
RX PubMed=23830731;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90290; probable.
ST Source(s): Cosmic-CLP; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 14,15
ST D19S433: 13,15
ST D21S11: 28,31.2
ST D2S1338: 17,19
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 10,14
ST FGA: 21,22
ST Penta D: 11,12
ST Penta E: 7,11
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H292
AC CVCL_0455
SY H292; H-292; NCI-HUT-292; Hut292; NCIH292
DR BTO; BTO:0002418
DR CLO; CLO_0008080
DR EFO; EFO_0006690
DR MCCL; MCC:0000353
DR CLDB; cl3653
DR CLDB; cl3654
DR ATCC; CRL-1848
DR BCRC; 60372
DR BCRJ; 0187
DR BioSample; SAMN03471312
DR CCLE; NCIH292_LUNG
DR CCRID; 3111C0001CCC000233
DR CCRID; 3131C0001000700122
DR ChEMBL-Cells; CHEMBL3308637
DR ChEMBL-Targets; CHEMBL614733
DR Cosmic; 753604
DR Cosmic; 844598
DR Cosmic; 877404
DR Cosmic; 1017828
DR Cosmic; 1047099
DR Cosmic; 1152499
DR Cosmic; 1188584
DR Cosmic; 1288262
DR Cosmic; 1466803
DR Cosmic; 1519249
DR Cosmic; 1520933
DR Cosmic; 1520947
DR Cosmic; 1870272
DR Cosmic; 1995573
DR Cosmic-CLP; 753604
DR ECACC; 91091815
DR GDSC; 753604
DR GEO; GSM206489
DR GEO; GSM784237
DR GEO; GSM794281
DR GEO; GSM888505
DR GEO; GSM1670237
DR ICLC; HTL96009
DR KCB; KCB 200822YJ
DR KCLB; 21848
DR SKY/M-FISH/CGH; 2844
RX PubMed=8806092;
RX PubMed=15193437;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 21848; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,13
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 10
ST D8S1179: 11,14
ST FGA: 22,26
ST Penta D: 9
ST Penta E: 13,15
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C45544; Lung mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H2925
AC CVCL_Y291
SY H2925; H-2925
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H295
AC CVCL_0456
SY H295; H-295; NCI-H-295
DR BTO; BTO:0002587
DR CLO; CLO_0008081
DR MCCL; MCC:0000502
DR ATCC; CRL-10296
DR BCRC; 60354
DR BioSample; SAMN03471298
DR Cosmic; 684682
DR Cosmic; 908466
DR Cosmic; 1179076
DR Cosmic; 2239455
DR Cosmic; 2364100
DR TOKU-E; 2687
DR Wikidata; Q28226675
RX PubMed=2386954;
RX PubMed=8056157;
RX PubMed=8404594;
RX PubMed=8806089;
RX PubMed=8806092;
RX PubMed=15541570;
RX PubMed=21924324;
RX PubMed=22266826;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-402.html
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11
ST D5S818: 12
ST D7S820: 9,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H295A
AC CVCL_0457
SY H295A; H-295A
DR BTO; BTO:0005669
DR MCCL; MCC:0000354
RX PubMed=9024219;
RX PubMed=15541570;
RX PubMed=18000308;
RX PubMed=21924324;
RX PubMed=22266826;
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H295R
AC CVCL_0458
SY H295R; H-295R; H295R-S1
DR BTO; BTO:0002588
DR CLO; CLO_0008082
DR EFO; EFO_0002289
DR MCCL; MCC:0000355
DR ATCC; CRL-2128
DR CCRID; 3111C0001CCC000256
DR ChEMBL-Cells; CHEMBL3307998
DR ChEMBL-Targets; CHEMBL612593
DR CLS; 300483/p789_NCI-H295R
DR Cosmic; 1172633
DR Cosmic; 1191070
DR Cosmic; 1622873
DR Cosmic; 2364101
DR Cosmic; 2574494
DR IGRhCellID; NCIH295R
DR Wikidata; Q25323725
RX PubMed=15541570;
RX PubMed=18000308;
RX PubMed=21924324;
RX PubMed=22266826;
RX PubMed=23951072;
WW https://en.wikipedia.org/wiki/H295R
ST Source(s): ATCC; CLS
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11
ST D18S51: 17
ST D21S11: 32.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 13
ST FGA: 19.2,24
ST Penta D: 8
ST Penta E: 5,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H295R-S2
AC CVCL_S901
SY H295R-S2
RX PubMed=21924324;
RX PubMed=22266826;
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H295R-S3
AC CVCL_S902
SY H295R-S3
RX PubMed=21924324;
RX PubMed=22266826;
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0456 ! NCI-H295
SX Female
CA Cancer cell line
//
ID NCI-H2973
AC CVCL_E105
SY H2973; H-2973
RX PubMed=11030152;
RX PubMed=12759538;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H298
AC CVCL_A556
SY H298; H-298
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H3026
AC CVCL_Y292
SY H3026; H-3026
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3030
AC CVCL_Y293
SY H3030; H-3030
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3072
AC CVCL_Y294
SY H3072; H-3072
RX PubMed=11030152;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3118
AC CVCL_A464
SY H3118; H-3118
DR Cosmic; 1288269
DR Cosmic; 1519250
DR Cosmic-CLP; 1240140
DR GDSC; 1240140
DR GEO; GSM1669832
DR SKY/M-FISH/CGH; 2845
RX PubMed=11030152;
RX PubMed=15193437;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,14
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H3122
AC CVCL_5160
SY H3122; H-3122; NCIH3122
DR Cosmic; 755472
DR Cosmic; 914951
DR Cosmic; 1146912
DR Cosmic; 2245571
DR Cosmic-CLP; 1240190
DR GDSC; 1240190
DR GEO; GSM253349
DR GEO; GSM434307
DR GEO; GSM794370
DR GEO; GSM1374739
DR GEO; GSM1374740
DR GEO; GSM1670238
DR IGRhCellID; H3122GEO
DR PRIDE; PXD002556
RX PubMed=11030152;
RX PubMed=12759538;
RX PubMed=20679594;
RX PubMed=24675041;
RX PubMed=26361996;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=20679594;
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7,9.3
ST TPOX: 10
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3123
AC CVCL_Y295
SY H3123; H-3123
RX PubMed=11030152;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3166
AC CVCL_X979
SY H3166; H-3166
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H3211
AC CVCL_X978
SY H3211; H-3211
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H322
AC CVCL_1556
SY H322; H-322; H322T; NCI-H322T; NCI-322
DR BTO; BTO:0003007
DR CLO; CLO_0008083
DR EFO; EFO_0006691
DR CLDB; cl3655
DR ATCC; CRL-5806
DR BioSample; SAMN03471699
DR BioSample; SAMN03471740
DR BioSample; SAMN03473287
DR CCLE; NCIH322_LUNG
DR ChEMBL-Cells; CHEMBL3307405
DR ChEMBL-Targets; CHEMBL614573
DR Cosmic; 687822
DR Cosmic; 801589
DR Cosmic; 844830
DR Cosmic; 876143
DR Cosmic; 903571
DR Cosmic; 917976
DR Cosmic; 929972
DR Cosmic; 932922
DR Cosmic; 934547
DR Cosmic; 980962
DR Cosmic; 1028935
DR Cosmic; 1032434
DR Cosmic; 1146913
DR Cosmic; 1152500
DR Cosmic; 1239903
DR Cosmic; 1802317
DR Cosmic; 1870261
DR Cosmic; 1891884
DR Cosmic; 2042867
DR Cosmic; 2125250
DR ECACC; 95111734
DR GEO; GSM206490
DR GEO; GSM253358
DR GEO; GSM434333
DR GEO; GSM784245
DR GEO; GSM794282
DR GEO; GSM827434
DR GEO; GSM887426
DR GEO; GSM888506
DR GEO; GSM1374741
DR IGRhCellID; NCIH322
DR KCLB; 90322
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=20679594;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: We are not certain that NCI-H322 and NCI-H322M are identical.
CC Discontinued: ATCC; CRL-5806; true.
CC Discontinued: KCLB; 90322; probable.
ST Source(s): ATCC; ECACC; PubMed=11416159; PubMed=20679594; PubMed=25877200
ST Amelogenin: X,Y (ATCC; ECACC; PubMed=11416159; PubMed=20679594)
ST Amelogenin: X (PubMed=25877200)
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 17
ST D21S11: 28
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 22
ST Penta D: 10
ST Penta E: 7
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H322M
AC CVCL_1557
SY NCI.H322M; H322M; H-322M
DR BTO; BTO:0004182
DR ChEMBL-Cells; CHEMBL3307710
DR ChEMBL-Targets; CHEMBL614803
DR Cosmic; 875851
DR Cosmic; 905967
DR Cosmic; 974293
DR Cosmic; 1092620
DR Cosmic; 1175865
DR Cosmic; 1305348
DR Cosmic; 1312333
DR Cosmic; 1995574
DR Cosmic; 1998462
DR Cosmic-CLP; 905967
DR GDSC; 905967
DR GEO; GSM50215
DR GEO; GSM50278
DR GEO; GSM434296
DR GEO; GSM750802
DR GEO; GSM799342
DR GEO; GSM799405
DR GEO; GSM1153413
DR GEO; GSM1181269
DR GEO; GSM1181316
DR GEO; GSM1374742
DR GEO; GSM1670239
DR IGRhCellID; H322M_03GEO
DR SKY/M-FISH/CGH; 2797
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=11
WW http://tcpaportal.org/mclp/
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 35.3 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
CC Caution: We are not certain that NCI-H322 and NCI-H322M are identical.
ST Source(s): Cosmic-CLP; PubMed=19372543
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 17
ST D19S433: 14
ST D21S11: 28
ST D2S1338: 19,25
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 22
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1556 ! NCI-H322
SX Male
CA Cancer cell line
//
ID NCI-H324
AC CVCL_3953
SY H324; H-324
DR BTO; BTO:0003005
DR Cosmic; 844594
DR Cosmic; 877238
DR Cosmic; 877406
DR Cosmic; 903572
DR Cosmic; 1152501
DR Cosmic; 1891885
DR GEO; GSM794283
RX PubMed=8806092;
RX PubMed=20679594;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=20679594
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H3255
AC CVCL_6831
SY H3255; H-3255; H3255_DA
DR EFO; EFO_0003123
DR ATCC; CRL-2882
DR BioSample; SAMN03471808
DR CCLE; NCIH3255_LUNG
DR Cosmic; 897734
DR Cosmic; 903623
DR Cosmic; 914952
DR Cosmic; 1028937
DR Cosmic; 1128245
DR Cosmic; 1146914
DR Cosmic-CLP; 1247873
DR GDSC; 1247873
DR GEO; GSM63349
DR GEO; GSM253411
DR GEO; GSM434297
DR GEO; GSM794371
DR GEO; GSM827356
DR GEO; GSM1374743
DR GEO; GSM1669833
DR IGRhCellID; H3255_DAGEO
DR PRIDE; PXD002224
DR PRIDE; PXD002556
RX PubMed=11030152;
RX PubMed=12759538;
RX PubMed=20679594;
RX PubMed=26202522;
RX PubMed=26361996;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep membrane proteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2882; true.
ST Source(s): ATCC; Cosmic-CLP; PubMed=20679594;
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 11,13
ST D16S539: 8
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H3255DR
AC CVCL_DI56
SY H3255DR
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DI55 ! NCI-H3255GR
SX Female
CA Cancer cell line
//
ID NCI-H3255GR
AC CVCL_DI55
SY H3255GR; H3255 GR
DR Cosmic; 1128246
RX PubMed=16906227;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6831 ! NCI-H3255
SX Female
CA Cancer cell line
//
ID NCI-H3282
AC CVCL_X980
SY H3282; H-3282
RX PubMed=11030152;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NCI-H345
AC CVCL_1558
SY H345; H-345; NCI H345; NCIH345
DR BTO; BTO:0003019
DR CLO; CLO_0008084
DR EFO; EFO_0006692
DR ATCC; HTB-180
DR BioSample; SAMN03471018
DR BioSample; SAMN03472734
DR ChEMBL-Cells; CHEMBL3307324
DR ChEMBL-Targets; CHEMBL614195
DR Cosmic; 688021
DR Cosmic; 755464
DR Cosmic; 844551
DR Cosmic; 850440
DR Cosmic; 877206
DR Cosmic; 877355
DR Cosmic; 1006525
DR Cosmic; 1021860
DR Cosmic; 1152465
DR Cosmic; 1219101
DR Cosmic; 1239938
DR Cosmic; 2125251
DR Cosmic-CLP; 688021
DR GDSC; 688021
DR GEO; GSM169441
DR GEO; GSM380512
DR GEO; GSM784200
DR GEO; GSM794284
DR GEO; GSM844647
DR GEO; GSM1670240
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=25485619;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 8
ST D18S51: 12,13
ST D21S11: 29,31
ST D3S1358: 18
ST D5S818: 11,12 (ATCC; Cosmic-CLP)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 9,13
ST D8S1179: 14,16
ST FGA: 20
ST Penta D: 12,13
ST Penta E: 14
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H358
AC CVCL_1559
SY H358; H-358; NCIH358
DR BTO; BTO:0002835
DR CLO; CLO_0008085
DR EFO; EFO_0002291
DR CLDB; cl3656
DR ATCC; CRL-5807
DR BioSample; SAMN03471313
DR CCLE; NCIH358_LUNG
DR CCRID; 3131C0001000700151
DR ChEMBL-Cells; CHEMBL3307543
DR ChEMBL-Targets; CHEMBL614135
DR Cosmic; 722039
DR Cosmic; 724875
DR Cosmic; 877106
DR Cosmic; 903573
DR Cosmic; 908465
DR Cosmic; 910563
DR Cosmic; 914944
DR Cosmic; 929970
DR Cosmic; 934545
DR Cosmic; 980963
DR Cosmic; 1004699
DR Cosmic; 1028934
DR Cosmic; 1032435
DR Cosmic; 1052333
DR Cosmic; 1146915
DR Cosmic; 1219075
DR Cosmic; 1239902
DR Cosmic; 1600603
DR Cosmic; 1741780
DR Cosmic; 1802307
DR Cosmic; 1870273
DR Cosmic; 1995575
DR Cosmic; 2042868
DR Cosmic-CLP; 908465
DR ECACC; 95111733
DR GDSC; 908465
DR GEO; GSM206491
DR GEO; GSM253398
DR GEO; GSM385520
DR GEO; GSM385531
DR GEO; GSM434257
DR GEO; GSM513937
DR GEO; GSM514321
DR GEO; GSM784251
DR GEO; GSM794285
DR GEO; GSM827468
DR GEO; GSM844648
DR GEO; GSM887427
DR GEO; GSM888507
DR GEO; GSM1374744
DR GEO; GSM1670241
DR IGRhCellID; NCIH358
DR KCLB; 25807
DR KCLB; 90358
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=8806101;
RX PubMed=9649128;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-368.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 38 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 12,13
ST D18S51: 14
ST D21S11: 28,30
ST D3S1358: 14,18
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 20,21
ST Penta D: 10,13
ST Penta E: 18
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H360
AC CVCL_A557
SY H360; H-360
DR Cosmic; 1152466
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H369
AC CVCL_A558
SY H369; H-369
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H372
AC CVCL_A559
SY H372; H-372
DR Cosmic; 844552
DR Cosmic; 1152467
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H378
AC CVCL_1560
SY H378; H-378; NCIH378
DR CLO; CLO_0008086
DR ATCC; CRL-5808
DR BioSample; SAMN03471741
DR ChEMBL-Cells; CHEMBL3308295
DR ChEMBL-Targets; CHEMBL2366088
DR Cosmic; 688022
DR Cosmic; 850428
DR Cosmic; 877207
DR Cosmic; 877356
DR Cosmic; 980932
DR Cosmic; 1021861
DR Cosmic; 1032398
DR Cosmic; 1152468
DR Cosmic; 1995576
DR Cosmic-CLP; 688022
DR GDSC; 688022
DR GEO; GSM794286
DR GEO; GSM845546
DR GEO; GSM844649
DR GEO; GSM1670242
DR IGRhCellID; NCIH378
DR KCLB; 90378
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11030152;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 16,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A560 ! NCI-H379
SX Female
CA Cancer cell line
//
ID NCI-H379
AC CVCL_A560
SY H379; H-379
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1560 ! NCI-H378
SX Female
CA Cancer cell line
//
ID NCI-H432
AC CVCL_A563
SY H432; H-432
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A564 ! NCI-H433
SX Male
CA Cancer cell line
//
ID NCI-H433
AC CVCL_A564
SY H433; H-433
DR Cosmic; 1152469
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Subcutaneous nodules.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A563 ! NCI-H432
SX Male
CA Cancer cell line
//
ID NCI-H441
AC CVCL_1561
SY H441; H-441; NCI-H441-4; NCI-441; NCIH441
DR BTO; BTO:0001910
DR CLO; CLO_0008087
DR EFO; EFO_0002292
DR ATCC; HTB-174
DR ATCC; CRM-HTB-174
DR BCRC; 60455
DR BCRJ; 0359
DR BioSample; SAMN03473121
DR CCLE; NCIH441_LUNG
DR ChEMBL-Cells; CHEMBL3308121
DR ChEMBL-Targets; CHEMBL1075542
DR Cosmic; 687824
DR Cosmic; 722048
DR Cosmic; 801590
DR Cosmic; 844831
DR Cosmic; 876144
DR Cosmic; 897730
DR Cosmic; 903574
DR Cosmic; 908460
DR Cosmic; 914949
DR Cosmic; 917992
DR Cosmic; 1006533
DR Cosmic; 1028948
DR Cosmic; 1052332
DR Cosmic; 1146916
DR Cosmic; 1219076
DR Cosmic; 1239882
DR Cosmic; 1802306
DR Cosmic; 1870274
DR Cosmic; 1945871
DR Cosmic; 1995577
DR Cosmic; 2042863
DR Cosmic; 2125252
DR Cosmic-CLP; 908460
DR GDSC; 908460
DR GEO; GSM206492
DR GEO; GSM253415
DR GEO; GSM353231
DR GEO; GSM385521
DR GEO; GSM385532
DR GEO; GSM434308
DR GEO; GSM784265
DR GEO; GSM794287
DR GEO; GSM827516
DR GEO; GSM844650
DR GEO; GSM887428
DR GEO; GSM888508
DR GEO; GSM1670243
DR IGRhCellID; NCIH441
DR IZSLER; BS TCL 215
DR PRIDE; PXD002556
RX PubMed=2386953;
RX PubMed=8806092;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-294.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC Doubling time: 80 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 9,13
ST D18S51: 18,19
ST D21S11: 32.2
ST D3S1358: 18
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 8,14
ST FGA: 24,25
ST Penta D: 10,12
ST Penta E: 12
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C5650; Papillary lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H441/CMV-Luc
AC CVCL_M254
DR JCRB; JCRB1497
DR JCRB; NIHS0728
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0728; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 9,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C5650; Papillary lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1561 ! NCI-H441
SX Male
CA Cancer cell line
//
ID NCI-H446
AC CVCL_1562
SY H446; H-446; NCI-446; NCIH446
DR CLO; CLO_0008088
DR EFO; EFO_0002293
DR ATCC; HTB-171
DR BioSample; SAMN03473283
DR CCLE; NCIH446_LUNG
DR CCRID; 3111C0001CCC000082
DR CCRID; 3131C0001000700038
DR ChEMBL-Cells; CHEMBL3307760
DR ChEMBL-Targets; CHEMBL612440
DR Cosmic; 688023
DR Cosmic; 755465
DR Cosmic; 801352
DR Cosmic; 844554
DR Cosmic; 877357
DR Cosmic; 897516
DR Cosmic; 929976
DR Cosmic; 932947
DR Cosmic; 1006526
DR Cosmic; 1021863
DR Cosmic; 1152471
DR Cosmic; 1219102
DR Cosmic; 1239939
DR Cosmic; 1434963
DR Cosmic; 1995578
DR Cosmic; 2125198
DR Cosmic-CLP; 688023
DR GDSC; 688023
DR GEO; GSM169448
DR GEO; GSM380477
DR GEO; GSM784254
DR GEO; GSM845547
DR GEO; GSM887429
DR GEO; GSM888509
DR GEO; GSM1670244
DR GEO; GSM1682798
DR IGRhCellID; NCIH446
DR KCB; KCB 200688YJ
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 8
ST D16S539: 12
ST D18S51: 12,13
ST D21S11: 28
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 12,13
ST Penta E: 9,10
ST TH01: 8,9.3
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H449
AC CVCL_A565
SY H449; H-449
DR Cosmic; 1021864
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A566 ! NCI-H450
SX Female
CA Cancer cell line
//
ID NCI-H450
AC CVCL_A566
SY H450; H-450
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A565 ! NCI-H449
SX Female
CA Cancer cell line
//
ID NCI-H460
AC CVCL_0459
SY NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460
DR BTO; BTO:0002207
DR CLO; CLO_0003601
DR CLO; CLO_0008089
DR EFO; EFO_0003044
DR MCCL; MCC:0000356
DR CLDB; cl1548
DR ATCC; HTB-177
DR BCRC; 60373
DR BioSample; SAMN03471184
DR CCLE; NCIH460_LUNG
DR CCLV; CCLV-RIE 0962
DR CCRID; 3111C0001CCC000355
DR CCRID; 3131C0001000700039
DR CGH-DB; 199-1
DR CGH-DB; 9186-4
DR ChEMBL-Cells; CHEMBL3307677
DR ChEMBL-Targets; CHEMBL396
DR Cosmic; 722064
DR Cosmic; 724876
DR Cosmic; 755469
DR Cosmic; 844595
DR Cosmic; 875852
DR Cosmic; 877263
DR Cosmic; 877407
DR Cosmic; 897508
DR Cosmic; 905943
DR Cosmic; 911996
DR Cosmic; 931371
DR Cosmic; 947356
DR Cosmic; 980964
DR Cosmic; 1006534
DR Cosmic; 1017826
DR Cosmic; 1028956
DR Cosmic; 1032436
DR Cosmic; 1044245
DR Cosmic; 1047102
DR Cosmic; 1089231
DR Cosmic; 1092621
DR Cosmic; 1146917
DR Cosmic; 1154605
DR Cosmic; 1152502
DR Cosmic; 1188592
DR Cosmic; 1219077
DR Cosmic; 1239922
DR Cosmic; 1305349
DR Cosmic; 1312334
DR Cosmic; 1434967
DR Cosmic; 1436013
DR Cosmic; 1477420
DR Cosmic; 1802310
DR Cosmic; 1870275
DR Cosmic; 1945869
DR Cosmic; 1995579
DR Cosmic; 1998463
DR Cosmic; 2042872
DR Cosmic; 2125199
DR Cosmic; 2433756
DR Cosmic-CLP; 905943
DR DSMZ; ACC-737
DR ENCODE; ENCBS398KLJ
DR ENCODE; ENCBS446PPO
DR ENCODE; ENCBS460OUE
DR ENCODE; ENCBS514AAA
DR ENCODE; ENCBS515AAA
DR ENCODE; ENCBS641PGO
DR ENCODE; ENCBS686KKP
DR ENCODE; ENCBS798ZFS
DR ENCODE; ENCBS814QPR
DR GDSC; 905943
DR GEO; GSM50216
DR GEO; GSM50279
DR GEO; GSM206493
DR GEO; GSM253335
DR GEO; GSM385522
DR GEO; GSM385533
DR GEO; GSM434334
DR GEO; GSM513936
DR GEO; GSM514322
DR GEO; GSM750809
DR GEO; GSM784193
DR GEO; GSM794288
DR GEO; GSM799343
DR GEO; GSM799406
DR GEO; GSM827469
DR GEO; GSM844652
DR GEO; GSM844651
DR GEO; GSM847076
DR GEO; GSM887430
DR GEO; GSM888510
DR GEO; GSM1153414
DR GEO; GSM1181352
DR GEO; GSM1181361
DR GEO; GSM1374746
DR GEO; GSM1374747
DR GEO; GSM1374748
DR GEO; GSM1557134
DR IGRhCellID; NCI-H460%20GEO
DR IZSLER; BS TCL 197
DR KCB; KCB 2010102YJ
DR KCLB; 30177
DR SKY/M-FISH/CGH; 2798
RX PubMed=1563005;
RX PubMed=2041050;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=15746151;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19472407;
RX PubMed=19941903;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23381221;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24135919;
RX PubMed=25120651;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=12
WW http://www.addexbio.com/productdetail?pid=39
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-613.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 17.8 hours (DTP); ~23 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 9
ST D18S51: 13,15
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 17,25
ST D3S1358: 15,18
ST D5S818: 9,10
ST D7S820: 9,12
ST D8S1179: 12
ST FGA: 21,23
ST Penta D: 11,13
ST Penta E: 5
ST TH01: 9.3
ST TPOX: 8 (ATCC; Cosmic-CLP; DSMZ; PubMed=19372543; PubMed=25877200)
ST TPOX: 9.3 (KCLB)
ST vWA: 17
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H460-Luc
AC CVCL_J264
DR JCRB; JCRB1407
DR JCRB; NIHS0658
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0658; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 9
ST D5S818: 9,10
ST D7S820: 9,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H460-luc2
AC CVCL_5J23
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124316.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H460-Red-Fluc
AC CVCL_5J07
SY NCI-H460 Red-Fluc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124316
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H460M
AC CVCL_3969
SY H460M; H-460M; H460-M
DR BTO; BTO:0002836
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0459 ! NCI-H460
SX Male
CA Cancer cell line
//
ID NCI-H462
AC CVCL_A567
SY H462; H-462
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A568 ! NCI-H463
SX Male
CA Cancer cell line
//
ID NCI-H463
AC CVCL_A568
SY H463; H-463
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A567 ! NCI-H462
SX Male
CA Cancer cell line
//
ID NCI-H478
AC CVCL_A569
SY H478; H-478
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H498
AC CVCL_1563
SY H498; H-498
DR CLO; CLO_0008090
DR ATCC; CCL-254
DR BioSample; SAMN03471385
DR GEO; GSM513915
DR GEO; GSM514302
DR GEO; GSM1448214
DR KCLB; 10254
RX PubMed=3479249;
RX PubMed=8806089;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Peritoneum.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 8,11
ST FGA: 22,24
ST TH01: 7
ST TPOX: 8
ST vWA: 15
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H508
AC CVCL_1564
SY NCI H508; NCIH508; H508; H-508
DR CLO; CLO_0008091
DR EFO; EFO_0002294
DR ATCC; CCL-253
DR BioSample; SAMN03471384
DR CCLE; NCIH508_LARGE_INTESTINE
DR Cosmic; 685870
DR Cosmic; 908442
DR Cosmic; 1479606
DR Cosmic; 1565529
DR Cosmic; 1708418
DR Cosmic-CLP; 908442
DR GDSC; 908442
DR GEO; GSM513916
DR GEO; GSM514303
DR GEO; GSM741253
DR GEO; GSM887431
DR GEO; GSM888511
DR GEO; GSM1448142
DR GEO; GSM1670245
DR IZSLER; BS TCL 214
DR KCLB; 10253
DR SKY/M-FISH/CGH; 5012
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 32 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Abdominal wall.
ST Source(s): ATCC; Cosmic-CLP; KCLB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 12
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 8,12
ST FGA: 24,25
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H510A
AC CVCL_1565
AS CVCL_3973
SY H510A; H-510A; NCI-H510; NCIH510; H510; H-510
DR BTO; BTO:0003023
DR CLO; CLO_0008092
DR EFO; EFO_0006693
DR ATCC; HTB-184
DR BioSample; SAMN03473048
DR CCLE; NCIH510_LUNG
DR ChEMBL-Cells; CHEMBL3308322
DR ChEMBL-Targets; CHEMBL2366332
DR Cosmic; 753605
DR Cosmic; 755466
DR Cosmic; 897519
DR Cosmic; 903575
DR Cosmic; 1006527
DR Cosmic; 1021865
DR Cosmic; 1219103
DR Cosmic; 1995580
DR Cosmic; 2125210
DR Cosmic-CLP; 753605
DR DSMZ; ACC-568
DR ECACC; 96020944
DR GDSC; 753605
DR GEO; GSM169437
DR GEO; GSM784199
DR GEO; GSM794289
DR GEO; GSM887432
DR GEO; GSM888512
DR GEO; GSM1670246
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~1 week (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Adrenal gland.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 15,17
ST D21S11: 30
ST D3S1358: 16,18
ST D5S818: 9,12
ST D7S820: 10,11
ST D8S1179: 15
ST FGA: 22
ST Penta D: 9,11
ST Penta E: 12,16
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 15
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H513
AC CVCL_A570
SY H513; H-513; HUT513
DR ATCC; CRL-5830
DR BioSample; SAMN03151854
DR Cosmic; 877271
DR Cosmic; 877408
DR Cosmic; 980997
DR Cosmic; 1032388
DR Cosmic; 1152503
DR Cosmic; 1995420
DR Cosmic-CLP; 1240141
DR GDSC; 1240141
DR GEO; GSM1669835
DR KCLB; 90513
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=23830731;
RX PubMed=27397505;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NCI-H125 derivative.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; CRL-5830; true.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 7
ST D13S317: 11
ST D16S539: 5,12
ST D5S818: 10
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3968 ! NCI-H125
SX Male
CA Cancer cell line
//
ID NCI-H520
AC CVCL_1566
SY H520; H-520; NCI-HUT-520; NCIH520
DR BTO; BTO:0003014
DR CLO; CLO_0008093
DR EFO; EFO_0003124
DR ATCC; HTB-182
DR BCRC; 60124
DR BioSample; SAMN03471318
DR BioSample; SAMN03472735
DR CCLE; NCIH520_LUNG
DR CCRID; 3111C0001CCC000197
DR ChEMBL-Cells; CHEMBL3307864
DR ChEMBL-Targets; CHEMBL614099
DR Cosmic; 687826
DR Cosmic; 801591
DR Cosmic; 876172
DR Cosmic; 908443
DR Cosmic; 917988
DR Cosmic; 929974
DR Cosmic; 932932
DR Cosmic; 933580
DR Cosmic; 945226
DR Cosmic; 1028955
DR Cosmic; 1146918
DR Cosmic; 1219078
DR Cosmic; 1239911
DR Cosmic; 1741782
DR Cosmic; 1802297
DR Cosmic; 1995581
DR Cosmic; 2060526
DR Cosmic; 2125253
DR Cosmic-CLP; 908443
DR GDSC; 908443
DR GEO; GSM63353
DR GEO; GSM206494
DR GEO; GSM276781
DR GEO; GSM276782
DR GEO; GSM434281
DR GEO; GSM784258
DR GEO; GSM794290
DR GEO; GSM844653
DR GEO; GSM844654
DR GEO; GSM887433
DR GEO; GSM888513
DR GEO; GSM1374750
DR GEO; GSM1670247
DR IGRhCellID; NCIH520
DR KCB; KCB 2013023YJ
RX PubMed=8806092;
RX PubMed=9649128;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,11
ST D16S539: 8,13
ST D18S51: 17
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 12,13 (ATCC; Cosmic-CLP)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 8,12
ST D8S1179: 14,16,17
ST FGA: 22
ST Penta D: 13
ST Penta E: 5,14
ST TH01: 10
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H522
AC CVCL_1567
SY NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522
DR BTO; BTO:0003536
DR CLO; CLO_0008094
DR EFO; EFO_0002295
DR ATCC; CRL-5810
DR BioSample; SAMN03471314
DR CCLE; NCIH522_LUNG
DR ChEMBL-Cells; CHEMBL3308392
DR ChEMBL-Targets; CHEMBL614387
DR Cosmic; 875853
DR Cosmic; 877409
DR Cosmic; 897509
DR Cosmic; 903576
DR Cosmic; 905944
DR Cosmic; 974294
DR Cosmic; 980965
DR Cosmic; 1004696
DR Cosmic; 1032437
DR Cosmic; 1044246
DR Cosmic; 1092622
DR Cosmic; 1146919
DR Cosmic; 1154592
DR Cosmic; 1175866
DR Cosmic; 1188591
DR Cosmic; 1219062
DR Cosmic; 1239883
DR Cosmic; 1305350
DR Cosmic; 1312335
DR Cosmic; 1436012
DR Cosmic; 1802320
DR Cosmic; 1870276
DR Cosmic; 1891886
DR Cosmic; 1995582
DR Cosmic; 1998464
DR Cosmic; 2125185
DR Cosmic-CLP; 905944
DR GDSC; 905944
DR GEO; GSM50217
DR GEO; GSM50280
DR GEO; GSM206495
DR GEO; GSM353230
DR GEO; GSM434309
DR GEO; GSM513965
DR GEO; GSM514350
DR GEO; GSM750798
DR GEO; GSM784233
DR GEO; GSM794291
DR GEO; GSM799344
DR GEO; GSM799407
DR GEO; GSM827479
DR GEO; GSM847077
DR GEO; GSM887434
DR GEO; GSM888514
DR GEO; GSM1153415
DR GEO; GSM1181345
DR GEO; GSM1181346
DR GEO; GSM1374751
DR GEO; GSM1374752
DR GEO; GSM1374753
DR GEO; GSM1670248
DR IGRhCellID; NCIH522
DR KCLB; 25810
DR KCLB; 90522
DR SKY/M-FISH/CGH; 2803
RX PubMed=1563005;
RX PubMed=2041050;
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19472407;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=7
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 38.2 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 25810; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12 (Cosmic-CLP; PubMed=19372543)
ST CSF1PO: 10 (ATCC; PubMed=25877200)
ST D13S317: 10
ST D16S539: 12
ST D18S51: 14,18
ST D19S433: 16
ST D21S11: 28,31.2
ST D2S1338: 17,20
ST D3S1358: 16
ST D5S818: 10,11 (PubMed=19372543)
ST D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D7S820: 9,10
ST D8S1179: 12,13
ST FGA: 24
ST Penta D: 11
ST Penta E: 11
ST TH01: 7,9.3
ST TPOX: 9,10
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H524
AC CVCL_1568
SY H524; H-524; NCIH524
DR BTO; BTO:0004825
DR CLO; CLO_0008095
DR EFO; EFO_0002296
DR ATCC; CRL-5831
DR BioSample; SAMN03472976
DR CCLE; NCIH524_LUNG
DR CCRID; 3111C0001CCC000356
DR ChEMBL-Cells; CHEMBL3308296
DR ChEMBL-Targets; CHEMBL2366342
DR Cosmic; 688024
DR Cosmic; 844555
DR Cosmic; 850442
DR Cosmic; 877208
DR Cosmic; 877358
DR Cosmic; 908483
DR Cosmic; 980933
DR Cosmic; 1032399
DR Cosmic; 1152472
DR Cosmic; 1759289
DR Cosmic; 1891904
DR Cosmic; 2125200
DR Cosmic-CLP; 908483
DR GDSC; 908483
DR GEO; GSM169442
DR GEO; GSM794292
DR GEO; GSM845548
DR GEO; GSM887435
DR GEO; GSM888515
DR GEO; GSM1670249
DR IGRhCellID; NCIH524
DR KCB; KCB 2010137YJ
DR KCLB; 90524
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 100 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90524; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 12,13
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 25
ST Penta D: 12,13
ST Penta E: 5,15
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 14,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H526
AC CVCL_1569
SY H526; H-526; NCIH526
DR BTO; BTO:0005366
DR CLO; CLO_0008096
DR ATCC; CRL-5811
DR BioSample; SAMN03473065
DR CCLE; NCIH526_LUNG
DR ChEMBL-Cells; CHEMBL3308881
DR ChEMBL-Targets; CHEMBL2366102
DR Cosmic; 688025
DR Cosmic; 755467
DR Cosmic; 801615
DR Cosmic; 844556
DR Cosmic; 844820
DR Cosmic; 850439
DR Cosmic; 876164
DR Cosmic; 877209
DR Cosmic; 877359
DR Cosmic; 918012
DR Cosmic; 929975
DR Cosmic; 1021866
DR Cosmic; 1152473
DR Cosmic; 1219104
DR Cosmic; 1239940
DR Cosmic; 1891905
DR Cosmic; 1995583
DR Cosmic; 1998284
DR Cosmic; 2125214
DR Cosmic-CLP; 688025
DR GDSC; 688025
DR GEO; GSM169439
DR GEO; GSM380478
DR GEO; GSM380515
DR GEO; GSM536330
DR GEO; GSM784231
DR GEO; GSM794293
DR GEO; GSM845549
DR GEO; GSM844655
DR GEO; GSM887436
DR GEO; GSM888516
DR GEO; GSM1374754
DR GEO; GSM1670250
DR IGRhCellID; NCIH526
DR KCLB; 90526
DR TOKU-E; 2701
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=10037197;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 9
ST D18S51: 12,15
ST D21S11: 27,32.2
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 9,12
ST D8S1179: 14
ST FGA: 22
ST Penta D: 13,14
ST Penta E: 5,13
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H548
AC CVCL_1570
SY NCI H548; H548; H-548; NCIH548
DR CLO; CLO_0008097
DR ATCC; CCL-249
DR BioSample; SAMN03471379
DR GEO; GSM1374755
DR KCLB; 10249
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=20606684;
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CCL-249; true.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 11,13
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 9,11
ST FGA: 21,22
ST TH01: 7
ST TPOX: 10,11
ST vWA: 15,18,19 (ATCC)
ST vWA: 15,18 (KCLB)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H568
AC CVCL_A571
SY H568; H-568
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H571
AC CVCL_A572
SY H571; H-571
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H578
AC CVCL_A573
SY H578; H-578
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H580
AC CVCL_A574
SY H580; H-580
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H596
AC CVCL_1571
SY H596; H-596; NCI-HUT-596; NCIH596
DR BTO; BTO:0002209
DR CLO; CLO_0008098
DR EFO; EFO_0006694
DR ATCC; HTB-178
DR BioSample; SAMN03472805
DR CCLE; NCIH596_LUNG
DR CCRID; 3111C0001CCC000257
DR ChEMBL-Cells; CHEMBL3307791
DR ChEMBL-Targets; CHEMBL612256
DR Cosmic; 687828
DR Cosmic; 801586
DR Cosmic; 844832
DR Cosmic; 876226
DR Cosmic; 897514
DR Cosmic; 908459
DR Cosmic; 918001
DR Cosmic; 929973
DR Cosmic; 934548
DR Cosmic; 1067762
DR Cosmic; 1146920
DR Cosmic; 1188588
DR Cosmic; 1219079
DR Cosmic; 1239917
DR Cosmic; 1694668
DR Cosmic; 1802293
DR Cosmic; 1995584
DR Cosmic; 2125254
DR Cosmic-CLP; 908459
DR GDSC; 908459
DR GEO; GSM206496
DR GEO; GSM434310
DR GEO; GSM784243
DR GEO; GSM794294
DR GEO; GSM844656
DR GEO; GSM887437
DR GEO; GSM888517
DR GEO; GSM1374756
DR GEO; GSM1374757
DR GEO; GSM1670251
DR IGRhCellID; NCIH596
DR KCLB; 90596
DR PRIDE; PXD002556
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=8806101;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Part of: MD Anderson Cell Lines Project.
CC Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11
ST D18S51: 18
ST D21S11: 29
ST D3S1358: 14
ST D5S818: 11,13
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 23,25
ST Penta D: 13
ST Penta E: 12,15
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H60
AC CVCL_A592
SY H60; H-60
DR ATCC; CRL-5821
DR BioSample; SAMN03151862
DR Cosmic; 1021848
DR GEO; GSM1682797
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=6108156;
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
WW http://www.atcc.org/support/faqs/d296a/NCIH60%20ATCC%20CRL5821-1064.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NCI-N417 derivative.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5821; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 9
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1602 ! NCI-N417
SX Female
CA Cancer cell line
//
ID NCI-H606
AC CVCL_A575
SY H606; H-606
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H615
AC CVCL_A576
SY H615; H-615
RX PubMed=8806092;
RX PubMed=8806103;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H618
AC CVCL_A577
SY H618; H-618
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H620
AC CVCL_A578
SY H620; H-620
DR Cosmic; 1021868
DR Cosmic; 1998276
DR GEO; GSM536332
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H630
AC CVCL_1572
SY H630; H-630
DR CLO; CLO_0008099
DR EFO; EFO_0002297
DR ATCC; CRL-5833
DR BioSample; SAMN03151846
DR BioSample; SAMN03481113
DR ChEMBL-Cells; CHEMBL3307966
DR ChEMBL-Targets; CHEMBL612540
DR Cosmic; 687535
DR Cosmic; 908482
DR Cosmic; 1187327
DR Cosmic-CLP; 908482
DR GDSC; 908482
DR GEO; GSM452725
DR GEO; GSM452756
DR GEO; GSM453572
DR GEO; GSM454623
DR GEO; GSM454643
DR GEO; GSM454644
DR GEO; GSM454645
DR GEO; GSM1448143
DR GEO; GSM1670252
DR IGRhCellID; NCIH630
DR IZSLER; BS TCL 191
DR KCLB; 90630
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=27397505;
RX PubMed=25926053;
WW http://www.atcc.org/support/faqs/8fa42/NCIH630%20ATCC%20CRL5833-1065.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. The contaminant is not known. Seems to be a mixture of cell lines.
CC Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-5833; true.
CC Discontinued: KCLB; 90630; probable.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12,13,14 (ATCC)
ST D13S317: 11,12,13 (Cosmic-CLP)
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 8,11,12
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 15,16,17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Undefined cell line type
//
ID NCI-H64
AC CVCL_1573
SY H64; H-64
DR ATCC; CRL-5976
DR BioSample; SAMN03472629
DR ChEMBL-Cells; CHEMBL3308273
DR ChEMBL-Targets; CHEMBL2366319
DR Cosmic; 688026
DR Cosmic; 844544
DR Cosmic; 953985
DR Cosmic; 1995585
DR Cosmic-CLP; 688026
DR GDSC; 688026
DR GEO; GSM1670253
RX PubMed=2985257;
RX PubMed=6108156;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H640
AC CVCL_A579
SY H640; H-640
RX PubMed=8806092;
RX PubMed=11030152;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NCI-H647
AC CVCL_1574
SY H647; H-647; H647ell; NCIH647
DR BTO; BTO:0005294
DR CLO; CLO_0008100
DR ATCC; CRL-5834
DR BioSample; SAMN03471319
DR CCLE; NCIH647_LUNG
DR ChEMBL-Cells; CHEMBL3308691
DR ChEMBL-Targets; CHEMBL614999
DR Cosmic; 722060
DR Cosmic; 903577
DR Cosmic; 931370
DR Cosmic; 980966
DR Cosmic; 1032438
DR Cosmic; 1146921
DR Cosmic; 1891887
DR Cosmic-CLP; 1240191
DR GDSC; 1240191
DR GEO; GSM206497
DR GEO; GSM434311
DR GEO; GSM513970
DR GEO; GSM514351
DR GEO; GSM784213
DR GEO; GSM794295
DR GEO; GSM827587
DR GEO; GSM844657
DR GEO; GSM844658
DR GEO; GSM887438
DR GEO; GSM888518
DR GEO; GSM1374758
DR GEO; GSM1670254
DR IGRhCellID; H647GEO
DR KCLB; 90647
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: KCLB; 90647; probable.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,11
ST D16S539: 9
ST D18S51: 12,15
ST D21S11: 28,32.2
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 11,13
ST FGA: 22,24
ST Penta D: 12,13
ST Penta E: 7
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H650
AC CVCL_1575
SY H650; H-650
DR BTO; BTO:0004079
DR CLO; CLO_0008101
DR EFO; EFO_0002298
DR ATCC; CRL-5835
DR BioSample; SAMN03471315
DR CCLE; NCIH650_LUNG
DR ChEMBL-Cells; CHEMBL3308461
DR ChEMBL-Targets; CHEMBL1075543
DR Cosmic; 722066
DR Cosmic; 1609512
DR Cosmic; 1870277
DR Cosmic; 1995586
DR Cosmic-CLP; 722066
DR GDSC; 722066
DR GEO; GSM206498
DR GEO; GSM794296
DR GEO; GSM827481
DR GEO; GSM887439
DR GEO; GSM888519
DR GEO; GSM1670255
DR IGRhCellID; NCIH650
DR KCLB; 90650
RX PubMed=8806092;
RX PubMed=11030152;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 8,11
ST D18S51: 14,20
ST D21S11: 31
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 12,14
ST FGA: 20,22
ST Penta D: 12
ST Penta E: 12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H650-Luc
AC CVCL_4Y16
DR JCRB; NIHS0729
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1575 ! NCI-H650
SX Male
CA Cancer cell line
//
ID NCI-H660
AC CVCL_1576
SY H660; H-660; NCIH660; NCI660
DR BTO; BTO:0001970
DR CLO; CLO_0008102
DR ATCC; CRL-5813
DR BioSample; SAMN03473052
DR CCLE; NCIH660_PROSTATE
DR Cosmic; 877360
DR Cosmic; 1021869
DR Cosmic; 1043331
DR Cosmic; 1075272
DR Cosmic; 1689713
DR Cosmic-CLP; 1330975
DR GEO; GSM482672
DR GEO; GSM648822
DR GEO; GSM887440
DR GEO; GSM888520
DR GEO; GSM1670256
DR IGRhCellID; NCIH660
RX PubMed=1563005;
RX PubMed=2985257;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
RX PubMed=14518029;
RX PubMed=22460905;
RX PubMed=23671654;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://capcelllines.ca/details.asp?id=157
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 100 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11
ST D18S51: 15,16
ST D21S11: 28,31
ST D3S1358: 14,18
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 9,10
ST FGA: 23,24
ST Penta D: 9,12
ST Penta E: 12
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H661
AC CVCL_1577
SY H661; H-661; NCIH661
DR BTO; BTO:0003013
DR CLO; CLO_0008103
DR EFO; EFO_0002299
DR ATCC; HTB-183
DR BCRC; 60125
DR BioSample; SAMN03471326
DR CCLE; NCIH661_LUNG
DR CCRID; 3111C0001CCC000357
DR CCRID; 3131C0001000700121
DR ChEMBL-Cells; CHEMBL3308139
DR ChEMBL-Targets; CHEMBL1075544
DR Cosmic; 687829
DR Cosmic; 877410
DR Cosmic; 903578
DR Cosmic; 909909
DR Cosmic; 923400
DR Cosmic; 930610
DR Cosmic; 933579
DR Cosmic; 961835
DR Cosmic; 980967
DR Cosmic; 1006540
DR Cosmic; 1032439
DR Cosmic; 1146922
DR Cosmic; 1152504
DR Cosmic; 1219063
DR Cosmic; 1239923
DR Cosmic; 1995587
DR Cosmic; 2125186
DR Cosmic-CLP; 687829
DR GDSC; 687829
DR GEO; GSM185870
DR GEO; GSM206499
DR GEO; GSM253359
DR GEO; GSM434273
DR GEO; GSM784198
DR GEO; GSM794297
DR GEO; GSM827517
DR GEO; GSM887441
DR GEO; GSM888521
DR GEO; GSM1670257
DR IGRhCellID; NCIH661
DR IZSLER; BS TCL 218
DR KCB; KCB 200823YJ
RX PubMed=8806092;
RX PubMed=9649128;
RX PubMed=11030152;
RX PubMed=11369051;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 61 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 11
ST D21S11: 31,33.2
ST D3S1358: 15,16
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 10
ST FGA: 20
ST Penta D: 11,13
ST Penta E: 12,13
ST TH01: 8
ST TPOX: 8
ST vWA: 17
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H676B
AC CVCL_1578
SY H676B; H-676B; NCI-H676; H676; H-676
DR CLO; CLO_0008104
DR ATCC; HTB-179
DR BioSample; SAMN03472732
RX PubMed=8626706;
RX PubMed=8806092;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 10
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H678
AC CVCL_A580
SY H678; H-678
DR Cosmic; 1998277
DR GEO; GSM536333
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H679
AC CVCL_A581
SY H679; H-679
DR ATCC; CRL-5977
RX PubMed=1563005;
RX PubMed=8806092;
RX PubMed=11030152;
CC Discontinued: ATCC; CRL-5977; true.
DI NCIt; C4038; Lung carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H684
AC CVCL_9980
SY H684; H-684
DR CCLE; NCIH684_LIVER
DR GEO; GSM1448215
DR KCLB; 90684
RX PubMed=3479249;
RX PubMed=8806092;
RX PubMed=25926053;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): KCLB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,12
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 10,11
ST FGA: 23
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H689
AC CVCL_A582
SY H689; H-689
DR KCLB; 90689
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
CC Discontinued: KCLB; 90689; probable.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H69
AC CVCL_1579
SY NCI-H-69; NCI H69; H69; H-69; NCIH69; NCI-HUT-69; H69/P; NCI-H69C; H69C; H69c
DR BTO; BTO:0003022
DR CLO; CLO_0003609
DR CLO; CLO_0008105
DR EFO; EFO_0002300
DR CLDB; cl1552
DR ATCC; HTB-119
DR BioSample; SAMN03473085
DR CCLE; NCIH69_LUNG
DR CCRID; 3111C0001CCC000358
DR ChEMBL-Cells; CHEMBL3307712
DR ChEMBL-Targets; CHEMBL614805
DR CLS; 300185/p530_NCI-H69
DR Cosmic; 688027
DR Cosmic; 713879
DR Cosmic; 755459
DR Cosmic; 801610
DR Cosmic; 808518
DR Cosmic; 844545
DR Cosmic; 844817
DR Cosmic; 876167
DR Cosmic; 877351
DR Cosmic; 918010
DR Cosmic; 929160
DR Cosmic; 1006522
DR Cosmic; 1021849
DR Cosmic; 1152461
DR Cosmic; 1175859
DR Cosmic; 1212189
DR Cosmic; 1219096
DR Cosmic; 1239934
DR Cosmic; 1434964
DR Cosmic; 1571755
DR Cosmic; 1609516
DR Cosmic; 1995588
DR Cosmic; 1998272
DR Cosmic; 2125215
DR Cosmic; 2239080
DR Cosmic-CLP; 688027
DR ECACC; 91091802
DR GDSC; 688027
DR GEO; GSM169443
DR GEO; GSM380498
DR GEO; GSM536334
DR GEO; GSM784197
DR GEO; GSM794269
DR GEO; GSM827305
DR GEO; GSM845550
DR GEO; GSM844659
DR GEO; GSM887442
DR GEO; GSM888522
DR GEO; GSM1670258
DR IGRhCellID; NCIH69
DR IZSLER; BS TCL 172
DR KCLB; 30119
RX PubMed=2574988;
RX PubMed=2985257;
RX PubMed=2985258;
RX PubMed=3034934;
RX PubMed=6108156;
RX PubMed=7736387;
RX PubMed=8626706;
RX PubMed=8712684;
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=9212023;
RX PubMed=9559344;
RX PubMed=9744504;
RX PubMed=9815546;
RX PubMed=10037197;
RX PubMed=11005564;
RX PubMed=11030152;
RX PubMed=11414198;
RX PubMed=12569360;
RX PubMed=19472407;
RX PubMed=22460905;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X,Y (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
ST Amelogenin: X (CLS)
ST CSF1PO: 10,12 (ATCC; CLS; ECACC; KCLB)
ST CSF1PO: 10,13 (Cosmic-CLP; PubMed=25877200)
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12 (CLS)
ST D18S51: 12,15 (PubMed=25877200)
ST D21S11: 30,31.2
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 9
ST D8S1179: 13
ST FGA: 24
ST Penta D: 9,11
ST Penta E: 12
ST TH01: 8,9
ST TPOX: 10
ST vWA: 17 (Cosmic-CLP; PubMed=25877200)
ST vWA: 16,17 (ATCC; CLS; ECACC; KCLB)
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H69/CPR
AC CVCL_2137
SY H69/CPR
DR ECACC; 96042328
RX PubMed=1327513;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69/LX10
AC CVCL_2138
SY H69/LX10
DR ECACC; 96042331
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69/LX20
AC CVCL_2139
SY H69/LX20
DR CLO; CLO_0008106
DR ECACC; 96042332
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69/LX4
AC CVCL_2140
SY NCI H69-LX4; H69/LX4
DR ECACC; 96042329
RX PubMed=3011054;
RX PubMed=3034934;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 9
ST TH01: 8,9
ST TPOX: 10
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H69VCR/R
AC CVCL_3058
DR ECACC; 96042330
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9
ST TH01: 8,9
ST TPOX: 10
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1579 ! NCI-H69
SX Male
CA Cancer cell line
//
ID NCI-H711
AC CVCL_1580
SY H711; H-711
DR CLO; CLO_0008107
DR ATCC; CRL-5836
DR BioSample; SAMN03471749
DR Cosmic; 844557
DR Cosmic; 877211
DR Cosmic; 877361
DR Cosmic; 910709
DR Cosmic; 1032400
DR Cosmic; 1891906
DR Cosmic; 2125255
DR GEO; GSM169446
DR GEO; GSM827535
RX PubMed=8806092;
RX PubMed=8806103;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 9,13
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H716
AC CVCL_1581
SY NCI H716; H716; H-716; NCIH716
DR BTO; BTO:0004747
DR CLO; CLO_0008108
DR EFO; EFO_0002301
DR CLDB; cl3658
DR ATCC; CCL-251
DR BCRC; 60517
DR BioSample; SAMN03473254
DR CCLE; NCIH716_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000359
DR CCRID; 3131C0001001200002
DR ChEMBL-Cells; CHEMBL3308297
DR ChEMBL-Targets; CHEMBL2366106
DR Cosmic; 687536
DR Cosmic; 908458
DR Cosmic; 1995589
DR Cosmic; 2302001
DR Cosmic-CLP; 908458
DR GDSC; 908458
DR GEO; GSM513917
DR GEO; GSM514304
DR GEO; GSM887443
DR GEO; GSM888523
DR GEO; GSM1346850
DR GEO; GSM1374759
DR GEO; GSM1448144
DR GEO; GSM1670259
DR IGRhCellID; NCIH716
DR KCLB; 10251
DR SKY/M-FISH/CGH; 5013
RX PubMed=1359704;
RX PubMed=3479249;
RX PubMed=8806089;
RX PubMed=8806092;
RX PubMed=8806095;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 50 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,12
ST D18S51: 15,16
ST D21S11: 32.2
ST D3S1358: 16,18
ST D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D5S818: 12 (KCLB)
ST D7S820: 10,11
ST D8S1179: 15
ST FGA: 20,22
ST Penta D: 9
ST Penta E: 7,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C5543; Cecum adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NCI-H719
AC CVCL_1582
SY H719; H-719
DR CLO; CLO_0008109
DR ATCC; CRL-5837
DR BioSample; SAMN03471750
DR ChEMBL-Cells; CHEMBL3308551
DR ChEMBL-Targets; CHEMBL2366184
DR Cosmic; 688028
DR Cosmic; 844558
DR Cosmic; 877362
DR Cosmic; 924242
DR Cosmic; 980934
DR Cosmic; 1032401
DR Cosmic; 1152474
DR Cosmic; 2125256
DR GDSC; 924242
DR KCLB; 90719
RX PubMed=8806092;
RX PubMed=8806103;
RX PubMed=11030152;
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9
ST D3S1358: 14
ST D5S818: 13
ST D7S820: 10
ST FGA: 20
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
- 公告/新闻
